DWP-205 derivatives (Daewoong)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameDWP-205 derivatives (Daewoong)
Drug Alias Namephosphodiesterase 4 inhibitors (Daewoong)DWP-205297
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitorsTumor necrosis factor α inhibitors
TargetsTumor necrosis factor αPhosphodieterase 4
Therapy Area/IndicationsAsthmaArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaewoong Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsAsthmaArthritis

Other Information

ATC CodeN/A
Related LinksN/A